80 related articles for article (PubMed ID: 23982602)
21. Development of a novel score for early detection of hepatocellular carcinoma among high-risk hepatitis C virus patients.
El-mezayen HA; Darwish H
Tumour Biol; 2014 Jul; 35(7):6501-9. PubMed ID: 24687551
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review).
Reichl P; Mikulits W
Oncol Rep; 2016 Aug; 36(2):613-25. PubMed ID: 27278244
[TBL] [Abstract][Full Text] [Related]
23. State-of-the-art Hepatocellular Carcinoma Biomarker Detection by Biosensor Technology-a Review.
Uygun ZO
J Gastrointest Cancer; 2021 Sep; 52(3):1081-1085. PubMed ID: 34347247
[TBL] [Abstract][Full Text] [Related]
24. HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Attallah AM; Omran MM; Attallah AA; Abdallah SO; Farid K; Darwish H; El-Dosoky I; Shaker YM
Br J Cancer; 2013 Sep; 109(6):1657-65. PubMed ID: 23982602
[TBL] [Abstract][Full Text] [Related]
25. Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems.
Attallah AM; Omran MM; Attallah AA; Abdelrazek MA; Farid K; El-Dosoky I
Int J Clin Oncol; 2017 Apr; 22(2):332-339. PubMed ID: 27864623
[TBL] [Abstract][Full Text] [Related]
26. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
27. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
[TBL] [Abstract][Full Text] [Related]
29. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular adenoma: evaluation with contrast-enhanced ultrasound and MRI and correlation with pathologic and phenotypic classification in 26 lesions.
Manichon AF; Bancel B; Durieux-Millon M; Ducerf C; Mabrut JY; Lepogam MA; Rode A
HPB Surg; 2012; 2012():418745. PubMed ID: 22811588
[TBL] [Abstract][Full Text] [Related]
31. Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.
Lai Q; Melandro F; Pinheiro RS; Donfrancesco A; Fadel BA; Levi Sandri GB; Rossi M; Berloco PB; Frattaroli FM
Int J Hepatol; 2012; 2012():893103. PubMed ID: 22792474
[TBL] [Abstract][Full Text] [Related]
32. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines.
Barreiros AP; Piscaglia F; Dietrich CF
J Hepatol; 2012 Oct; 57(4):930-2. PubMed ID: 22739095
[No Abstract] [Full Text] [Related]
33. Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment.
Kew MC
World J Hepatol; 2012 Mar; 4(3):99-104. PubMed ID: 22489262
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of cytokeratin-1 in the diagnosis of hepatocellular carcinoma.
Attallah AM; El-Far M; Abdel Malak CA; Zahran F; Farid K; Omran MM; Zagloul H; El-Deen MS
Clin Chim Acta; 2011 Nov; 412(23-24):2310-5. PubMed ID: 21924253
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy.
Gonzalez SA; Keeffe EB
Clin Liver Dis; 2011 May; 15(2):297-306, vii-x. PubMed ID: 21689614
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]